Live tape
Top 8, mentions 7d6,464META1,688 mentions▲ +0.06GOOGL1,252 mentions▲ +0.03NVDA831 mentions▲ +0.09TSLA621 mentions▲ +0.05MSFT556 mentions▲ +0.06AMZN534 mentions▲ +0.04SPY511 mentions▲ +0.04AAPL471 mentions▲ +0.06

Equity · Healthcare

BTSG

NASDAQ

BrightSpring Health Services, Inc.

$55.70 −1.52% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 29, 2026
Price · Chart
Our own end-of-day closes 62 sessions
$75 $55 2 Jul 29 Sep

The line runs $69.07 on 2 July through $55.70 on 29 September, on a scale from $55 to $75. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of BTSG over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $69.07 on 2 July 2026 through $55.70 on 29 September 2026.

Market cap $11.0B
P/E (TTM) 33.8
52-week range $26.84 – $73
Avg volume 106.5K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 29, 2026

BTSG insider trades

SEC Form 4 · last 90 days · newest reported trade 14 Sep 2026
Open-market buys 0
Open-market sells 1
Net sold $874K
Non-trade filings 2
Date Insider Type Shares Value
14 Sep 2026 Greenwell Scott A. President, PharMerica Sell 15,099 $874K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
14 Sep 2026 Greenwell Scott A. President, PharMerica Option exercise 11,973 $267K
25 Jul 2026 ROUSSEAU JON B See Remarks Tax withheld 56,319 $4.11M

BTSG reported financials

SEC EDGAR XBRL

BTSG reported revenue of $12.9B for the fiscal year ended 31 Dec 2025. Net income over the same period was $190.7M.

Figure Reported Period
Revenue $12.9B 31 Dec 2025 fiscal year
Net income $190.7M 31 Dec 2025 fiscal year
Diluted EPS $0.87 31 Dec 2025 fiscal year
Total assets $6.0B 30 Jun 2026 at period end
Total equity $2.0B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

BTSG earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.38 —
31 Mar 2026 Q1 2026 $0.67 —
31 Dec 2025 FY 2025 $0.87 —
30 Sep 2025 Q3 2025 $0.26 —
30 Jun 2025 Q2 2025 $0.13 —
31 Mar 2025 Q1 2025 $0.14 —
31 Dec 2024 FY 2024 $-0.09 —
30 Sep 2024 Q3 2024 $-0.04 $2.91B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

BTSG institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a BTSG position for the quarter ended 30 Jun 2026 — a combined $436.7M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Marshall Wace Held (±25%) −0.7% shares 2,636,177 $183.8M
Viking Global Investors New position 1,618,237 $112.9M
Renaissance Technologies New position 760,801 $53.1M
Citadel Advisors Trimmed −83.3% shares 517,146 $36.1M
Millennium Management Trimmed −82.4% shares 237,030 $16.5M
Point72 Asset Management Trimmed −59.9% shares 192,145 $13.4M
Two Sigma Investments Trimmed −26.8% shares 113,140 $7.9M
AQR Capital Management Held (±25%) −7.7% shares 86,254 $6.0M
Man Group Trimmed −35.7% shares 70,628 $4.9M
D. E. Shaw & Co. Trimmed −61.0% shares 29,909 $2.1M

Source: SEC EDGAR 13F filings

BTSG fails-to-deliver

SEC CNS data

On 28 Aug 2026, 20 shares of BTSG failed to deliver (about $1K).

Settlement date Shares failed Notional % of shares out
28 Aug 2026 20 $1K <0.001%
17 Aug 2026 44 $3K <0.001%

Source: SEC fails-to-deliver (CNS) data